Research use only. Not for human or veterinary use.
Lab reports
Analysis reportAll specifications met

NAD+ 1000mg

Peptide Stock ref. PSV-2610-NJ1000-01

Lot
CP01260728101000C
Manufactured
28 July 2026
Tested by
Axiom Analytics Laboratories
Analysed
11 October 2026
Purity99.87%RP-HPLC, UV 214 nm
Content per vial1,045.2 mg104.5% of 1,000 mg label claim
IdentityConfirmedLC-MS (ESI+)

Test results

TestSpecificationResultOutcome
Identity (LC-MS): NAD+Within ±1 Da of 663.43 Da663.334 DaPass
Purity (RP-HPLC 214 nm)≥ 99.25%99.87%Pass
Net peptide contentWithin ±10% of 1000 mg1045.2 mg (104.5% of claim)Pass
Sterility (rapid PCR)No microbial DNA detectedNot detectedPass

About this report

Analysis reportAll specifications met

NAD+ 1000mg

Peptide Stock ref. PSV-2609-NJ1000-01

Lot
CP01260728101000C
Manufactured
28 July 2026
Tested by
Bioviridian
Analysed
14 September 2026
Purity99.73%RP-HPLC, 214 nm
Content per vial1,007.59 mg100.8% of 1,000 mg label claim
IdentityConfirmedLC-MS/MS

Test results

TestSpecificationResultOutcome
Identity (LC-MS/MS)NAD+NAD+Pass
Content (HPLC quantitation)—1007.59 mg (100.8% of claim)Pass
Overall purity (RP-HPLC 214 nm)—99.73%Pass

About this report

← All lab reports